Heme Oxygenase-1 Has Antitumoral Effects In Colorectal Cancer: Involvement of p53

ANDRES, NC; FERMENTO, ME; GANDINI,NA; LOPEZ ROMERO, A; FERRO, A; GONZALEZ DONNA, ML; CURINO, AC.; FACCHINETTI, M M

EXPERIMENTAL AND MOLECULAR PATHOLOGY.

ACADEMIC PRESS INC ELSEVIER SCIENCE

Año: 2014 vol. 97 p. 321 - 331

0014-4800

The expression of heme oxygenase-1 (HO-1) has been shown to be up-regulated in colorectal cancer (CRC), but the role it plays in this cancer type has not yet been addressed. The aims of this study have been to analyze HO-1 expression in human invasive CRC, evaluate its correlation with clinical and histo-pathological parameters and to investigate the mechanisms through which the enzyme influences tumor progression. We confirmed that HO-1 was over-expressed in human invasive CRC and found that the expression of the enzyme was associated with a longer overall survival time. In addition, we observed in a chemically-induced CRC animal model that total and nuclear HO-1 expression increase with tumor progression. Our investigation of the mechanisms involved in HO-1 action in CRC demonstrate that the protein reduces cell viability through induction of cell cycle arrest and apoptosis and, importantly, that a functional p53 tumor suppressor protein is required for these effects. This reduction in cell viability is accompanied by modulation of the levels of p21, p27, and cyclin D1 and by modulation of Akt and PKC pathways. Altogether, our results demonstrate an antitumoral role of HO-1 and points to the importance of p53 status in this antitumor activity.